Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01786603 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: Rasagiline
DRUG: Placebo

Sponsor

Richard Barohn, MD